NEXGEL to Participate in the iAccess Alpha Virtual Best Ideas Spring Investment Conference on March 25-26th, 2025
NEXGEL (NASDAQ: NXGL), a leading provider of medical and OTC products specializing in ultra-gentle, high-water-content hydrogels, has announced its participation in the upcoming iAccess Alpha Virtual Best Ideas Spring Investment Conference 2025.
The company's Chief Executive Officer, Adam Levy, will deliver a presentation on Tuesday, March 25th, 2025, at 9:30 a.m. ET. The two-day conference will take place on March 25-26, 2025, and interested parties can access the webcast through the provided link.
Investors seeking one-on-one meetings with Mr. Levy can arrange appointments through iAccess representatives or by contacting KCSA Strategic Communications.
NEXGEL (NASDAQ: NXGL), un fornitore leader di prodotti medicali e OTC specializzati in idrogeli ultra-delicati ad alta percentuale d'acqua, ha annunciato la sua partecipazione alla prossima iAccess Alpha Virtual Best Ideas Spring Investment Conference 2025.
Il CEO dell'azienda, Adam Levy, terrà una presentazione martedì 25 marzo 2025, alle 9:30 a.m. ET. La conferenza di due giorni si svolgerà dal 25 al 26 marzo 2025 e le parti interessate possono accedere al webcast tramite il link fornito.
Gli investitori che desiderano incontri individuali con il signor Levy possono organizzare appuntamenti tramite i rappresentanti di iAccess o contattando KCSA Strategic Communications.
NEXGEL (NASDAQ: NXGL), un proveedor líder de productos médicos y OTC especializados en hidrogeles ultra-suaves con alto contenido de agua, ha anunciado su participación en la próxima iAccess Alpha Virtual Best Ideas Spring Investment Conference 2025.
El director ejecutivo de la compañía, Adam Levy, dará una presentación el martes 25 de marzo de 2025, a las 9:30 a.m. ET. La conferencia de dos días se llevará a cabo del 25 al 26 de marzo de 2025 y las partes interesadas pueden acceder al webcast a través del enlace proporcionado.
Los inversores que deseen reuniones uno a uno con el Sr. Levy pueden organizar citas a través de representantes de iAccess o contactando a KCSA Strategic Communications.
NEXGEL (NASDAQ: NXGL)은 초부드럽고 높은 수분 함량의 하이드로겔 전문 의료 및 OTC 제품의 선도적인 공급업체로, 다가오는 iAccess Alpha Virtual Best Ideas Spring Investment Conference 2025에 참여한다고 발표했습니다.
회사의 CEO인 Adam Levy는 2025년 3월 25일 화요일 오전 9시 30분 ET에 발표를 할 예정입니다. 이틀 간의 회의는 2025년 3월 25일부터 26일까지 진행되며, 관심 있는 분들은 제공된 링크를 통해 웹캐스트에 접근할 수 있습니다.
Levy 씨와의 일대일 미팅을 원하는 투자자들은 iAccess 대표를 통해 약속을 잡거나 KCSA Strategic Communications에 연락하여 약속을 조율할 수 있습니다.
NEXGEL (NASDAQ: NXGL), un fournisseur leader de produits médicaux et OTC spécialisés dans les hydrogels ultra-doux à haute teneur en eau, a annoncé sa participation à la prochaine iAccess Alpha Virtual Best Ideas Spring Investment Conference 2025.
Le PDG de l'entreprise, Adam Levy, fera une présentation le mardi 25 mars 2025, à 9h30 ET. La conférence de deux jours se déroulera du 25 au 26 mars 2025, et les parties intéressées peuvent accéder au webinaire via le lien fourni.
Les investisseurs souhaitant des réunions en tête-à-tête avec M. Levy peuvent organiser des rendez-vous par l'intermédiaire des représentants d'iAccess ou en contactant KCSA Strategic Communications.
NEXGEL (NASDAQ: NXGL), ein führender Anbieter von medizinischen und OTC-Produkten, die sich auf ultra-sanfte, hochwasserhaltige Hydrogels spezialisiert haben, hat seine Teilnahme an der bevorstehenden iAccess Alpha Virtual Best Ideas Spring Investment Conference 2025 bekannt gegeben.
Der CEO des Unternehmens, Adam Levy, wird am Dienstag, den 25. März 2025, um 9:30 Uhr ET eine Präsentation halten. Die zweitägige Konferenz findet vom 25. bis 26. März 2025 statt, und interessierte Parteien können über den bereitgestellten Link auf das Webcast zugreifen.
Investoren, die Einzelgespräche mit Herrn Levy wünschen, können Termine über die Vertreter von iAccess oder durch Kontaktaufnahme mit KCSA Strategic Communications vereinbaren.
- None.
- None.
LANGHORNE, Pa., March 13, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels for healthcare and consumer applications, today announced that Adam Levy, Chief Executive Officer, will present at the iAccess Alpha Virtual Best Ideas Spring Investment Conference 2025 on March 25 and 26, 2025.
iAccess Alpha Virtual Conference Details:
Date: March 25-26, 2025
Presentation Day and Time: Tuesday, March 25th at 9:30 a.m. ET
Webcast: https://www.webcaster4.com/Webcast/Page/3083/52115
To schedule a one-on-one investor meeting with Mr. Levy, please contact your representatives at iAccess or email KCSA Strategic Communications at NEXGEL@KCSA.Com.
About NEXGEL, Inc.
NEXGEL is a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels. Based in Langhorne, Pa., the Company has developed and manufactured electron-beam, cross-linked hydrogels for over two decades. NEXGEL brands include SilverSeal®, Hexagels®, Turfguard®, Kenkoderm® and Silly George®. Additionally, NEXGEL has strategic contract manufacturing relationships with leading consumer healthcare companies.
Investor Contacts:
Valter Pinto, Managing Director
KCSA Strategic Communications
212.896.1254
NEXGEL@KCSA.com
FAQ
When is NXGL presenting at the iAccess Alpha Virtual Conference 2025?
How can investors attend NXGL's presentation at the iAccess Conference?
How can investors schedule one-on-one meetings with NXGL's CEO?
What products does NXGL specialize in?
